Related Experiment Videos
Obstructive sleep apnea in children: do intranasal corticosteroids help?
Gillian M Nixon1, Robert T Brouillette
1Department of Pediatrics, Montreal Children's Hospital, Montreal, Quebec, Canada.
Summary
Childhood obstructive sleep apnea (OSA) may improve with intranasal corticosteroids, which reduce adenoid size. Systemic steroids are less effective and have side effects, warranting further study of nasal steroid efficacy for pediatric OSA.
Area of Science:
- Pediatric Pulmonology
- Otolaryngology
- Allergy and Immunology
Background:
- Obstructive sleep apnea (OSA) is a prevalent childhood condition linked to significant morbidity, often caused by enlarged adenoids and tonsils.
- Adenoid and tonsil enlargement obstruct the nasopharynx, leading to airway collapse during sleep, a primary mechanism in pediatric OSA.
- While systemic corticosteroids can reduce lymphoid tissue, short courses show limited efficacy for adenoidal size and OSA severity in children, with adverse effects limiting long-term use.
Purpose of the Study:
- To evaluate the efficacy of intranasal corticosteroids in reducing adenoid size and improving obstructive sleep apnea (OSA) severity in children.
- To explore the potential benefits of intranasal corticosteroids as an alternative treatment for pediatric OSA, considering their known effects on allergic rhinitis and nasal obstruction.
Main Methods:
- Review of existing literature on corticosteroid use for pediatric OSA and adenoid hypertrophy.
- Analysis of studies investigating the effects of intranasal corticosteroids on adenoid size, independent of atopic status.
- Examination of preliminary evidence regarding the impact of intranasal corticosteroid therapy on OSA severity in pediatric populations.
Main Results:
- Intranasal corticosteroids have demonstrated effectiveness in reducing nasal obstruction associated with allergic rhinitis.
- Studies indicate that intranasal corticosteroids can reduce adenoid size, irrespective of a child's allergic sensitization status.
- Preliminary data suggests a potential improvement in OSA severity in children treated with intranasal corticosteroids, though further research is required.
Conclusions:
- Intranasal corticosteroids show promise for reducing adenoid size and potentially improving pediatric obstructive sleep apnea (OSA).
- Further clinical trials are necessary to establish the routine recommendation and optimal use of intranasal corticosteroids for treating childhood OSA.
- Clinicians should consider patient age, comorbidities like allergic rhinitis, and specific treatment parameters when prescribing intranasal corticosteroids for pediatric OSA.